Current frontline endocrine treatment options for women with hormone receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced-stage breast cancer

by Hikmat Abdel-Razeq
Published 2019-03-01

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!

by Hikmat Abdel-Razeq
Published 2021-06-01

Patterns and Prevalence of Germline BRCA1 and BRCA2 Mutations among High-Risk Breast Cancer Patients in Jordan: A Study of 500 Patients

by Hikmat Abdel-Razeq, Lama Abujamous, Dima Jadaan
Published 2020-01-01

Cancer care in Jordan

by Hikmat Abdel-Razeq, Fadwa Attiga, Asem Mansour
Published 2015-06-01

Inferior vena cava filters in patients with advanced-stage cancer

by Asem Mansour, Yousef Ismael, Hikmat Abdel-Razeq
Published 2014-12-01

The Application of Gail Model to Predict the Risk of Developing Breast Cancer among Jordanian Women

by Hikmat Abdel-Razeq, Luna Zaru, Ahmed Badeeb, Shadi Hijjawi
Published 2020-01-01

Inferior vena cava filters in cancer patients: to filter or not to filter

by Hikmat Abdel-Razeq, Asem Mansour, Yousef Ismael, et al
Published 2011-03-01

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan

by Hikmat Abdel-Razeq, Amal Al-Omari, Farah Zahran, Banu Arun
Published 2018-02-01

Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Mi...

by Amal Al-Tabba', Maysa Al-Hussaini, Maysa Al-Hussaini, Razan Mansour, Hala Sultan, Hikmat Abdel-Razeq, Hikmat Abdel-Razeq, Asem Mansour, Asem Mansour
Published 2020-10-01

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan

by Hikmat Abdel-Razeq, Lama Abujamous, Mahmoud Abunasser, Sara Edaily, Rayan Bater
Published 2021-07-01

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients

by Hikmat Abdel-Razeq, Hikmat Abdel-Razeq, Mohammad Ma’koseh, Rashid Abdel-Razeq, Rula Amarin, Alaa Abufara, Razan Mansour, Mohammad Manasrah, Mohammad Al-Rwashdeh, Rayan Bater
Published 2021-05-01

The impact of recently published negative erythropoiesis-stimulating agent studies on the clinical management of cancer-related anemia at a single center

by Hikmat Abdel-Razeq, Shadi Hijjawi, Hazem Abdulelah, Rula Amarin, Majid Asawaeer, Haitham Shaheen
Published 2010-04-01

Tumor characteristics and treatment outcomes of older patients with breast cancer in Jordan

by Hikmat Abdel-Razeq, Fadwa Abdel Rahman, Hanan Almasri, Hazem Abdulelah, Mahmoud Abunasser, Mourad Salam, Ayat Taqash
Published 2020-06-01

Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents

by Hikmat Abdel-Razeq, Salwa S. Saadeh, Razan Malhis, Sameer Yasser, Hazem Abdulelah, Rana Eljaber, Amer Kleib, Rouba Ismael
Published 2020-09-01

Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients

by Hikmat Abdel-Razeq, Sereen Iweir, Rashid Abdel-Razeq, Fadwa Abdel Rahman, Hanan Almasri, Rayan Bater, Ayat Taqash, Hadeel Abdelkhaleq
Published 2021-07-01

The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma

by Hikmat Abdel-Razeq, Mohammad Ma’koseh, Asem Mansour, Rayan Bater, Rula Amarin, Alaa Abufara, Khalid Halahleh, Mohammad Manassra, Mohammad Alrwashdeh, Mohammad Almomani, Mais Zmaily
Published 2021-09-01

Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives

by Anna Falanga, Grégoire Le Gal, Marc Carrier, Hikmat Abdel-Razeq, Cihan Ay, Andrés J. Muñoz Martin, Ana Thereza Cavalcanti Rocha, Giancarlo Agnelli, Ismail Elalamy, Benjamin Brenner
Published 2021-07-01

Metaplastic Breast Carcinoma: Experience of a Tertiary Cancer Center in the Middle East

by Ayah Erjan MD, Hanan Almasri MD, Hikmat Abdel-Razeq MD, Mahmoud Al-Masri MD, Hussam Haddad MD, Anoud Alnsour MD, Fadwa Abdel Rahman MD, Abdulmajeed Dayyat MD
Published 2021-04-01

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

by Hikmat Abdel-Razeq, Asem Mansour, Hazem Abdulelah, Anas Al-Shwayat, Mohammad Makoseh, Mohammad Ibrahim, Mahmoud Abunasser, Dalia Rimawi, Abeer Al-Rabaiah, Rozan Alfar, Alaa’ Abufara, Alaa Ibrahim, Anas Bawaliz, Yousef Ismael
Published 2018-03-01

Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study

by Hikmat Abdel-Razeq MD, Faris Tamimi MD, Rashid Abdel-Razeq MD, Samer Salah MD, Zaid Omari MD, Osama Salama MD, Alaa Abufara MD, Abdalla Al-Tell MD, Hanna Qahoush MD, Ahmad Nasman MD, Ayat Taqash BSc, Yazan Alhalaseh MD, Rayan Bater MSc
Published 2021-06-01